Protective and destructive effects of microbial infection in insulin-dependent diabetes mellitus

Seminars in Immunology

Volumn 10, Issue 1, 1998, Pages 79-86

  Singh, Bhagirath ^a   Prange, Sean ^a   Jevnikar, Anthony M ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

BCG immunotherapy; IDDM; Immunopathogenesis; Immunoregulation; Microbial infection; NOD mice; Tolerance; Type I diabetes

Indexed keywords

CELL ANTIGEN; SUPERANTIGEN;

ANTIGEN BINDING; BACTERIAL INFECTION; CROSS REACTION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MIMICRY; MONOZYGOTIC TWINS; NONHUMAN; PANCREAS ISLET BETA CELL; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0032005163     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1997.0107     Document Type: Article

References (61)

1. 1. Singh B, Rabinovitch A (1993) Influence of microbial agents on the development of autoimmune diabetes. Autoimmunity 15:209-213
2. 2. Fohlman J, Friman G (1993) Is juvenile diabetes a viral disease? Ann Med 25:569-574
3. 3. Yoon JW (1990) The role of viruses and environmental factors in the induction of diabetes. Curr Top Microbiol Immunol 164:95-123
4. 4. Maclaren NK, Atkinson MA (1997) Insulin-dependent diabetes mellitus: the hypothesis of molecular mimicry between islet cell antigens and microorganisms. Mol Med Today 3:76-83
5. 5. Todd JA (1992) Genetic analysis of a susceptibility to type I diabetes. Springer Semin Immunolopathol 14:33-58
6. 6. Wicker LS, Todd JA Peterson LB (1995) Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13:179-200
7. 7. Leiter EH (1990) The role of environmental factors in modulating insulin dependent diabetes, in The Role of Microorganisms in Non-infectious disease (de Vries RRP, Cohen IR, van Rood JJ, eds), pp 39-55. Springer Verlag, Berlin
8. 8. Karges W, Hammond-McKibben D, Cheung RK, Viscanti M, Shibuya N, Kemp D, Dosch DH (1997) Immunological aspects of nutritional diabetes prevention in NOD mice: a pilot study for the cow's milk-based IDDM prevention trial. Diabetes 46:557-664
9. 9. Scott FW, Cloutiert HE, Kleemann R, Woerz-Pagenstert U, Rowsell P, Modler HW, Kolb H (1997) Potential mechanism by which certain food promote or inhibit the development of spontaneous diabetes in BB rats: dosage, timing, early effect on islet area, and switch in filtrate from Th1 to Th2 cells. Diabetes 46:589-598
10. 10. Bach J-F (1994) Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516-542
11. 11. Pozzilli P, Signore A Williams AJ, Beales PE (1993) NOD mouse colonies around the world-recent facts and figures. Immunol Today 14:193-6
12. 12. Wucherpfennig KW, Strominger JL (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695-705
13. 13. Helfand RF, Gary HE Jr, Freeman CY, Anderson LJ, Pallansch MA (1995) Serologie evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Res Group. J Infect Dis 172:1206-11
14. 14. Graves PM, Norris JM, Pallansch MA, Gerling IC, Rewers M (1997) The role of enteroviral infections in the development of IDDM. Diabetes 46:161-168
15. 15. Luppi P, Trucco M (1996) Superantigens in insulin-dependent diabetes mellitus. Springer Semin Immunopathol 17:333-62
16. 16. Dyrberg T, MacKay P, Michelsen B, Petersen J, Karlsen A, Bonnevie V (1996) Virus and Diabetes Mellitus, in Microorganisms and Autoimmune diseases (Friedman H, Rose NR, Bendinelli M, eds), pp 105-127. Plenum Press, New York
17. 17. Buesa-Gomez J, de la Torre JC, Dyrberg T, Landin-Olssan M, Mauseth RS, Lernmark A, Oldstan MB (1994) Failure to detect genomic viral sequences in pancreatic tissue from two childern with acute-onset diabetes mellitus. J Med Virol 42:193-197
18. 18. Guberski DL, Thomas VA, Shek WR, Like AA, Handler ES, Rossini AA, Wallace JE, Welsh RM (1991) Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science 254:1010-1013
19. 19. Yoon J-W (1991) Role of viruses in the pathogenesisof IDDM. Ann Med 23:437-45
20. 20. Rabinovitch A (1994) Immunoregulatory and cytokine imbalances in the pathogenesisof IDDM. Therapeutic intervention by immunostimulation? Diabetes 43:613-21
21. 21. Zechel M, Chaturvedi P, Singh B (1997) Characetrization of immunodominant peptide determinants of IDDM-associated autoantigens in the NOD mice. Res Immunol 148:338-348
22. 22. Rider BJ, Fraga E, Yu Q, Singh B (1996) Immune responses to self peptides naturally presented by MHC class II molecules. Mol Immunol 33:625-633
23. 23. Agrawal B, Manickasundari M, Fraga E, Singh B (1991) T cells exist in syngeneic mice which recognize peptide sequences of self MHC Class II molecules. J Immunol 147:383-390
24. 24. Chaturvedi P, Qin H-Y, Chou H, Singh B (1997) Modulation of Insulin dependent diabetes mellitus (IDDM) in NOD mice by autoreactive T cells. Crit Rev Immunol 17:519-528
25. 25. Gautam AM, Pearson CI, Lock CB, Steinman L, Smilek DE, McDevitt HO (1994) Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implication s in induction of autoimmunity. Proc Natl Acad Sci USA 91:767-71
26. 26. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO (1993) Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72-75
27. 27. Kaufman DL, Clare SM, Tian J, Forsthuber T, Ting GS, Robinson P, Atkinson MA, Sercarz EF, Tobin AJ, Lehmann PV (1993) Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes [see comments]. Nature 366:69-72
28. 28. Karounos DG, Wolinsky JS, Thomas JW (1993) Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen. J Immunol 150:3080-3085
29. 29. Atkinson MA, Bowman MA, Campbell L, Darrow B, Kaufmann DL, Maclaren NK (1994) Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependet diabetes mellitus. J Clin Invest 94:2125-2129
30. 30. Tian J, Lehmann PV, Kaufmann DL (1994) T cell reactivity between Coxsackie virus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 180:1979-1984
31. 31. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammom G (1993) Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 14:203-208
32. 32. Kappler JW, Roehm N, Marrack P (1987) T cell tolerance by clonal elimination in the thymus. Cell 49:273-280
33. 33. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi YI, Stauffacher C, Straniger JL, Wiley DC (1994) Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368:711-718
34. 34. Acha-Orbea H (1996) Superantigens of mouse mammary tumour virus: implications for diabetes? Diabetes Metab Rev 12:111-119
35. 35. Lafon M, Lafage M, Martinez-Arends A. et al (1992) Evidence in humans of a viral superantigen. Nature 358:507-509
36. 36. Conrad B, Weidmann E, Trucco G et al (1994) Evidence for a superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371:351-355
37. 37. Conrad B, Weissmahr NR, Böni J, Arcari R, Schüpbach J, Mach B (1997) A human endogenous retroviral superantigen as candidate autoimmune gene in type I diatetes. Cell 90:303-313
38. 38. Kawamura T, Nagata M, Utsugi T, Yoon JW (1993) Prevention of autoimmune type I diabetes by CD4 + suppressor T cells in superantigen-treated non-obese diabetic mice. J Immunol 151:4362-70
39. 39. Shimada A, Taylor-Edwards C, Charlton B, Fathman CG (1996) Beta-cell destruction maybe a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 45:1063-1067
40. 40. Gazda LS, Charlton B, Lafferty KJ (1997) Diabetes results from a late change in the autoimmune response of NOD mice. J Autoimmunity 10:261-270
41. 41. Singh B, Dillon T, Fraga E, Lauzon J (1990) Role of the first external domain of I-A beta chain in immune responses and diabetes in non-obese diabetic (NOD) mice. J Autoimmunity 3:507-21
42. 42. Todd JA Bell JI, McDevitt HO (1987) HLA-DQ β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604
43. 43. Hanson MS, Cetkovic-Cvrlje M, Ramiya VK, Atkinson MA, Maclaren NK, Singh B, Elliott JF, Serreze DV, Leiter EH (1996) Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J Immunol 157:1279-87
44. 44. Nepom GT, Erlich H (1991) MHC class-II molecules and autoimmunity. Annu Rev Immunol 9:493-525
45. 45. Deng H, Apple R, Clare SM, Trembleau S, Math is D, Adorini L, Sercarz E (1993) Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J Exp Med 178:1675-1680
46. 46. Abbas AK, Sher A, Murphy KM (1996) Functional diversity of helper T lymphocytes. Nature 383:787-793
47. 47. Shevach E (1997) Microbial products induce autoimmune disease by an IL-12-dependent pathway. J Immunol 158:5087-5090
48. 48. Chaturvedi P, Yu Q, Southwood S, Sette A Singh B (1996) Peptide analogs with different affinities for MHC alter the cytokine profile of T helper cells. Int Immunol 8:745-755
49. 49. Pakala SV, Kurrer MO, Katz JD (1997) T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) Mice. J Exp Med 186:299-306
50. 50. Sadclain MW, Qin HY, Lauzon J, Singh B (1990) Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39:583-589
51. 51. Sadelain MWJ, Qin HY, Samoski W, Parfrey N, Singh B, Rabinovitch A (1990) Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J Autoimmunity 3:671-680
52. 52. Qin HY, Sadelain MW, Hitchon C, Lauzon J, Singh B (1993) Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J Immunol 150:2072-2080
53. 53. Shehadeh NN, Calcinaro F, Bradley B, Bruchlim I, Vardi P, Lafferty KJ (1994) Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 343:706-707
54. 54. Shehadeh NN, LaRosa F, Lafferty KJ (1993) Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 6:291-300
55. 55. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF (1996) IFN-g gene expression in pancretic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol 154:4874-4882
56. 56. Qin HY, Elliott JF, Rajotte RV, Singh B (1996) Endogenous immune responses to glutamic acid decarboxylase (GAD67) in NOD mice are modulated by adjuvant immunotherapy. Autoimmunity 24(suppl 1):37
57. 57. Qin HY, Singh B (1997) BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease accleration with cyclophosphamide. J Autoimmunity 10:271-278
58. 58. Lakey JR, Singh B, Warnock GL, Rajotte RV (1994) BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice. Transplantation 57:1213-1217
59. 59. Singh B, Elliott JF (1997) Can progression of IDDM be prevented in newly diagnosed patients by BCG immunotherapy? Diabetes Prev Ther 11:12-13
60. 60. Singh B (1997) Possible immunological treatment for Type I diabetes in the 21st century. Pract Diabetes Int 14(in press)
61. 61. Ma SW, Zhao DL, Ym ZQ, Mukherjee R, Singh B, Qin HY, Stiller CR, Jevnikar AM (1997) Transgenic plants expressing autoantigens fed to mice to induce oral tolerance. Nature Medicine 3:793-796